Challenging The Admissibility Of Regulatory Findings

Law360, New York (April 26, 2010, 12:21 PM EDT) -- The International Agency for Research on Cancer (IARC) coordinates research on the causes of human cancer and develops scientific strategies for cancer control. IARC concludes various substances and events (silica, asbestos, benzene, etc.) are known, probable or possible carcinogens.

A plaintiff diagnosed with cancer files a product liability suit against the manufacturer of a product alleging the plaintiff’s cancer was caused by exposure to a “carcinogenic” substance incorporated in or emitted from a particular product. To establish causation, the plaintiff relies on IARC’s designation of the...
To view the full article, register now.